Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency
- PMID: 36826710
- DOI: 10.1007/s11845-023-03321-w
Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency
Abstract
Objective: Anxiety and depression commonly occur and correlate with poor prognosis in patients with cancer. The study aimed to assess the anxiety and depression in patients with postsurgical non-small cell lung cancer (NSCLC) using both Hospital Anxiety and Depression Scale (HADS) and Self-Rating Anxiety/Depression Scale (SAS/SDS) and to investigate their risk factors and linkage with prognosis.
Methods: HADS and SAS/SDS were assessed in 350 patients with NSCLC at 3 months after surgical resection and 100 healthy controls (HCs). Patients with NSCLC were followed up for a median period of 27.0 (range: 6.0-52.0) months for prognostic evaluation.
Results: HADS-identified anxiety rate (39.7% vs. 10.0%, P < 0.001), SAS-identified anxiety rate (34.9% vs. 9.0%, P < 0.001), HADS-identified depression rate (29.7% vs. 5.0%, P < 0.001), and SDS-identified depression rate (27.1% vs. 6.0%, P < 0.001) were all elevated in patients with NSCLC vs. HCs. Multivariate logistic regression analysis uncovered that diabetes, adjuvant therapy, postoperative complications, and poor differentiation were independently linked with increased HADS- or SAS-identified anxiety risk (all P < 0.05); meanwhile, female gender, hypertension, diabetes, poor differentiation, adjuvant therapy, postoperative complications, and TNM stage were independently linked with increased HADS- or SDS-identified depression risk (all P < 0.05). Furthermore, HADS-identified anxiety, SAS-identified anxiety, HADS-identified depression, and SDS-identified depression independently predicted shorter disease-free survival and overall survival (all P < 0.05).
Conclusion: Anxiety and depression are prevalent and linked with poor survival in patients with postsurgical NSCLC. Meanwhile, gender, comorbidities, advanced tumor features, adjuvant therapy, and postoperative complications relate to the prevalence of anxiety and depression.
Keywords: Anxiety; Depression; Non-small cell lung cancer; Risk factors; Survival.
© 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Similar articles
-
Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China.Medicine (Baltimore). 2020 Mar;99(11):e19087. doi: 10.1097/MD.0000000000019087. Medicine (Baltimore). 2020. PMID: 32176035 Free PMC article.
-
Hospital anxiety and depression scale exhibits good consistency but shorter assessment time than Zung self-rating anxiety/depression scale for evaluating anxiety/depression in non-small cell lung cancer.Medicine (Baltimore). 2021 Feb 26;100(8):e24428. doi: 10.1097/MD.0000000000024428. Medicine (Baltimore). 2021. PMID: 33663054 Free PMC article.
-
Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.Ir J Med Sci. 2021 Aug;190(3):1155-1164. doi: 10.1007/s11845-020-02374-5. Epub 2020 Nov 2. Ir J Med Sci. 2021. PMID: 33140294
-
Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.Ir J Med Sci. 2023 Dec;192(6):2621-2629. doi: 10.1007/s11845-023-03318-5. Epub 2023 Mar 2. Ir J Med Sci. 2023. PMID: 36862310
-
A review of 250 ten-year survivors after pneumonectomy for non-small-cell lung cancer.Eur J Cardiothorac Surg. 2014 May;45(5):876-81. doi: 10.1093/ejcts/ezt494. Epub 2013 Oct 16. Eur J Cardiothorac Surg. 2014. PMID: 24132299 Review.
Cited by
-
Psychosocial factors influencing the outcomes after major anatomical lung resections: a retrospective analysis of prospectively collected data.J Thorac Dis. 2025 Jul 31;17(7):4969-4977. doi: 10.21037/jtd-2024-1974. Epub 2025 Jul 29. J Thorac Dis. 2025. PMID: 40809236 Free PMC article.
-
Global research and emerging trends in depression in lung cancer: a bibliometric and visualized study from 2014 to 2024.Front Oncol. 2025 Mar 5;15:1490108. doi: 10.3389/fonc.2025.1490108. eCollection 2025. Front Oncol. 2025. PMID: 40110200 Free PMC article.
-
Latent class analysis of depression among patients with non-small cell lung cancer after surgery: A cross-sectional study.PLoS One. 2025 Jun 17;20(6):e0324723. doi: 10.1371/journal.pone.0324723. eCollection 2025. PLoS One. 2025. PMID: 40526697 Free PMC article.
-
Investigation of Exercise Interventions on Postoperative Recovery in Lung Cancer Patients: A Qualitative Study Using Web Crawling Technology.Patient Prefer Adherence. 2024 Sep 24;18:1965-1977. doi: 10.2147/PPA.S478576. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39345759 Free PMC article.
-
Anxiety, depression, and quality of life in postoperative non-small cell lung cancer patients under the intervention of cognitive-behavioral stress management.Front Psychol. 2023 May 31;14:1138070. doi: 10.3389/fpsyg.2023.1138070. eCollection 2023. Front Psychol. 2023. PMID: 37325749 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590 - DOI - PubMed
-
- Nasim F, Sabath BF, Eapen GA (2019) Lung cancer. Med Clin North Am 103(3):463–473. https://doi.org/10.1016/j.mcna.2018.12.006 - DOI - PubMed
-
- Zhang Z, Yang S, Ma Y et al (2021) Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review. Transl Lung Cancer Res 10(6):2715–2732. https://doi.org/10.21037/tlcr-21-423
-
- Bassanelli M, Ramella S, Zeuli M, Ceribelli A (2022) Radiotherapy and immunotherapy: the power of the teamwork for the treatment of NSCLC. Anticancer Res 42(5):2241–2247. https://doi.org/10.21873/anticanres.15704
-
- Yang Q, Luo LC, Li FM et al (2022) Survival outcomes of radiofrequency ablation compared with surgery in patients with early-stage primary non-small-cell lung cancer: a meta-analysis. Respir Investig 60(3):337–344. https://doi.org/10.1016/j.resinv.2022.01.002 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical